Oxford University Resuming Vaccine Trial After Side Effect Detected

The video discusses the temporary pause of the AstraZeneca coronavirus vaccine trial due to an unexplained side effect experienced by a volunteer. The trial has resumed in the UK, with safety being the primary focus. Dr. Francis Collins from the NIH reassures that such pauses are standard practice to ensure safety. Oxford University did not disclose the side effect, but reports suggest it was transverse myelitis. Another pause occurred in July due to an unrelated case of multiple sclerosis. The video also highlights the scale of the trials and AstraZeneca's vaccine as a leading candidate among others in late-stage testing.

Why was the coronavirus vaccine trial initially paused?

• Due to a lack of volunteers

• Because of an unexplained side effect in a volunteer

• The trial was completed

• The vaccine was found ineffective

What condition was reported by the New York Times as a side effect in the vaccine trial?

• Multiple sclerosis

• Transverse myelitis

• Influenza

• Pneumonia

What was the reason for the brief pause in trials in July?

• Completion of the trial phase

• A volunteer had an undiagnosed case of multiple sclerosis

• The vaccine was ineffective

• Lack of funding

How many volunteers are being recruited for the vaccine trials in the US?

• 40,000

• 10,000

• 20,000

• 30,000

Which company is partnering with Oxford University to develop the potential vaccine?

• Johnson & Johnson

• AstraZeneca

• Moderna

• Pfizer